Evidence map›Paper›PMID 30128547›Full record

ArticleJAMA ophthalmology2018

Research Questions and Outcomes Prioritized by Patients With Dry Eye.

Ian J Saldanha, Rebecca Petris, Genie Han, Kay Dickersin, Esen K Akpek

Abstract read
In one paragraph

Article in JAMA ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Lubricating drops for contact lens discomfort in adults.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. Topical corticosteroids for dry eye.The Cochrane database of systematic reviews · 2022
    Pooled it
  4. Pooled it
  5. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.The Cochrane database of systematic reviews · 2019
    Pooled it
  6. Topical cyclosporine A therapy for dry eye syndrome.The Cochrane database of systematic reviews · 2019
    Pooled it
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Topical lifitegrast therapy for dry eye disease.The Cochrane database of systematic reviews · 2025
    Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Ian J SaldanhaCenter for Evidence Synthesis in Health, Brown University School of Public Health, Providence, Rhode Island.
Rebecca PetrisDry Eye Company LLC, Poulsbo, Washington.
Genie HanConsumers United for Evidence-Based Healthcare, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Kay DickersinDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Esen K AkpekWilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland.

Funding

Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US ProjectUG1EY020522 · NEI · UNIVERSITY OF COLORADO DENVER · PI Tianjing Li · 2017 to 2026
$10.1M
Comparative Effectiveness Research & the Cochrane Eyes & Vision GroupU01EY020522 · NEI · JOHNS HOPKINS UNIVERSITY · PI DICKERSIN, KAY · 2010 to 2016
$9.2M
Comparative Effectiveness & Medical Interventions for Primary Open Angle GlaucomaRC1EY020140 · NEI · JOHNS HOPKINS UNIVERSITY · PI DICKERSIN, KAY · 2009 to 2010
$901k
NEI NIH HHS RC1 EY020140NEI NIH HHS U01 EY020522NEI NIH HHS UG1 EY020522
6 · The paper itself

Abstract

Importance: Dry eye is a common ocular surface condition with significant influence on patient quality of life and societal economic burden. There is an urgent need to prioritize new research for dry eye. Objective: To identify and rank research questions and outcomes important to patients with dry eye. Design, Setting, and Participants: This study was conducted using the following 6 steps: (1) identifying research questions from a previous survey of clinicians who treat patients with dry eye; (2) identifying outcomes from existing research (systematic reviews and their cited clinical trials in the Cochrane Eyes and Vision US Satellite database of eyes and vision reviews, and National Eye Institute-funded clinical trials registered on ClinicalTrials.gov) as of June 13, 2017; (3) identifying a sample of patients with dry eye from the email subscribers to the online newsletter KeratoScoop; (4) and (5) conducting a 2-round Delphi survey of those patients online in November and December 2017, respectively; and (6) designating and ranking questions and outcomes as important. Main Outcomes and Measures: Importance assigned to research questions and outcomes for dry eye. A research question or outcome ranked by at least 75% of patients as 6 or higher on a scale of 0 to 10 was considered important. Results: Among the 420 patients from 15 countries who completed both rounds of the Delphi survey, most were 60 years of age or older (233 [56%]), female (348 [83%]), white (393 [94%]), and of non-Hispanic ethnicity (398 [95%]). Among the 12 questions that clinicians had previously prioritized, patients rated 8 as important. The top 3 questions pertained to effectiveness of patient education, environmental modifications, and topical anti-inflammatory eye drops for dry eye. Among the 109 outcomes identified in existing research on dry eye, patients rated 26 as important. Ten of these 26 were unpopular in existing research, with fewer than 10% of 158 studies reporting these outcomes. Of the 10 most important outcomes, 9 were associated with symptoms or quality of life. The 3 outcomes rated most important by patients were ocular burning or stinging, ocular discomfort, and ocular pain. Conclusions and Relevance: This study identified research questions and outcomes important to patients with dry eye. A considerable gap was noted between outcomes in existing research on dry eye and outcomes patients consider important. Future research on dry eye should consider addressing the important research questions and outcomes identified herein, taking into account the patient perspective.

Indexed as

Administration, OphthalmicAdultAgedAged, 80 and overAnti-Inflammatory AgentsBiomedical ResearchDelphi TechniqueDry Eye SyndromesEnvironmental MonitoringFemaleHealth Care SurveysHumansMaleMiddle AgedOphthalmic SolutionsPatient Education as TopicAnti-Inflammatory AgentsOphthalmic Solutions

Identifiers

PMID30128547
PMCPMC6218931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.